MicroRNA reduction of neuronal West Nile virus replication attenuates and affords a protective immune response in mice.

[1]  R. Balling,et al.  Characterization of Differentiated SH-SY5Y as Neuronal Screening Model Reveals Increased Oxidative Vulnerability , 2016, Journal of biomolecular screening.

[2]  Thomas R. Gingeras,et al.  A Genome-Wide Survey of Sexually Dimorphic Expression of Drosophila miRNAs Identifies the Steroid Hormone-Induced miRNA let-7 as a Regulator of Sexual Identity , 2014, Genetics.

[3]  T. Gingeras,et al.  A Genome-Wide Survey of Sexually Dimorphic Expression of Drosophila miRNAs Identifies the Steroid Hormone-Induced miRNA let-7 as a Regulator of Sexual Identity. , 2014, G3.

[4]  O. Maximova,et al.  Silencing of neurotropic flavivirus replication in the central nervous system by combining multiple microRNA target insertions in two distinct viral genome regions. , 2014, Virology.

[5]  A. Brault,et al.  West Nile virus: review of the literature. , 2013, JAMA.

[6]  S. Pradervand,et al.  Comprehensive Expression Analyses of Neural Cell-Type-Specific miRNAs Identify New Determinants of the Specification and Maintenance of Neuronal Phenotypes , 2013, The Journal of Neuroscience.

[7]  B. tenOever.  RNA viruses and the host microRNA machinery , 2013, Nature Reviews Microbiology.

[8]  A. Brault,et al.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system , 2012, Archives of Virology.

[9]  Olga A. Maximova,et al.  MicroRNA Targeting of Neurotropic Flavivirus: Effective Control of Virus Escape and Reversion to Neurovirulent Phenotype , 2012, Journal of Virology.

[10]  M. Quiñones,et al.  Patterns of microRNA Expression in Non-Human Primate Cells Correlate with Neoplastic Development In Vitro , 2010, PloS one.

[11]  L. Petersen,et al.  West Nile fever characteristics among viremic persons identified through blood donor screening. , 2010, The Journal of infectious diseases.

[12]  P. Shi,et al.  RNA Structures Required for Production of Subgenomic Flavivirus RNA , 2010, Journal of Virology.

[13]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[14]  Pei-Yong Shi,et al.  A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. , 2008, Cell host & microbe.

[15]  C. DiGuiseppi,et al.  Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007. , 2008, The American journal of tropical medicine and hygiene.

[16]  S. Russell,et al.  Engineering microRNA responsiveness to decrease virus pathogenicity , 2008, Nature Medicine.

[17]  M. Vignuzzi,et al.  Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. , 2008, Cell host & microbe.

[18]  A. Hüttenhofer,et al.  Anopheles gambiae miRNAs as actors of defence reaction against Plasmodium invasion , 2007, Nucleic acids research.

[19]  T. Maniatis,et al.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. , 2007, Molecular cell.

[20]  C. Huang,et al.  Avian virulence and thermostable replication of the North American strain of West Nile virus. , 2006, The Journal of general virology.

[21]  Daniel R. O’Leary,et al.  Epidemiology and Transmission Dynamics of West Nile Virus Disease , 2005, Emerging infectious diseases.

[22]  J. Sejvar,et al.  Virology, Pathology, and Clinical Manifestations of West Nile Virus Disease , 2005, Emerging infectious diseases.

[23]  A. Brault,et al.  Differential Virulence of West Nile Strains for American Crows , 2004, Emerging infectious diseases.

[24]  Roderick C. Jones,et al.  Clinical Characteristics and Functional Outcomes of West Nile Fever , 2004, Annals of Internal Medicine.

[25]  L. Petersen,et al.  West Nile Virus: A Primer for the Clinician , 2002, Annals of Internal Medicine.

[26]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[27]  Farzad Mostashari,et al.  Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey , 2001, The Lancet.

[28]  C. Huang,et al.  Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus Vaccine , 2000, Journal of Virology.

[29]  J. Drake,et al.  Mutation rates among RNA viruses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Brinton,et al.  Sequence and secondary structure analysis of the 5'-terminal region of flavivirus genome RNA. , 1988, Virology.

[31]  M. Brinton,et al.  The 3'-nucleotides of flavivirus genomic RNA form a conserved secondary structure. , 1986, Virology.

[32]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[33]  T. Ross,et al.  West Nile virus. , 2010, Clinics in laboratory medicine.